Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous ketorolac plus magnesium sulfate versus ketorolac plus placebo for pain relief in Colles' fracture
IRCT20120215009014N329Phase 2Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Colles fracture comparing Ketorolac + magnesium sulfate with Ketorolac + placebo (2 arms). Primary endpoint: Severity of pain. Started Jan 2020; status: completed.
02
Drugs
ketorolacmagnesium sulfate
03
Conditions
Colles fracture
Beyond the preview
Go deeper on IRCT20120215009014N329.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N329.